Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êàðäèîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé êàðäèîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #91  
Ñòàðûé 14.03.2007, 13:45
Delsol Delsol âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
 
Ðåãèñòðàöèÿ: 06.03.2007
Ñîîáùåíèé: 143
Delsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDelsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ostroumov
Óâàæàåìîìó Delsol ìîãó ïðåäëîæèòü çàãëÿíóòü â íûíå çàêðûòóþ íà çàìîê òåìó "Íåîáû÷íàÿ ÝÊà ïîñëå ÀÊØ?". Åñëè äàæå Âû íå íàéäåòå òàì ïîëíîãî îòâåòà íà Âàø âîïðîñ, òîò íàéäåòå ëèòåðàòóðíûå ññûëêè è íàøå ìíåíèå. Ñ óâàæåíèåì êî âñåì âàì. ÎÅÍ
Âîçìîæíî è ñóùåñòâóþò ïóáëèêàöèè ïîääåðæèâàþùèå âàøó òî÷êó çðåíèÿ. Íî âñå æå áîëüøèíñòâî êàðäèîëîãîâ ñ÷èòàåò, ÷òî æèçíåñïîñîáíîñòü ìèîêàðäà äëÿ ðåøåíèÿ âîïðîñà î ðåâàñêóëÿðèçàöèè íóæíî îöåíèâàòü èíà÷å. Èçâèíèòå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #92  
Ñòàðûé 14.03.2007, 13:52
Àâàòàð äëÿ M_Osipov
M_Osipov M_Osipov âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2007
Ãîðîä: Òàðóñà, Ìîñêâà
Ñîîáùåíèé: 53
M_Osipov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåM_Osipov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Çà ñîâåòû âñåì -- áîëüøîå ðóññêîå merci. À ïðî ÏÊÀ-òî, ÷òî ñêàæåòå, äîðîãîé saab?
Äà, è åùå ïî ïîâîäó ñîâåòîâ ä-ðà Alex'a íå åñòü æèðíîãî âñïîìíèë öèòàòó èç "Íîñà", î÷åíü ïîäõîäÿùóþ ê ñëó÷àþ.

- Âåðèòå ëè, - ñêàçàë äîêòîð íè ãðîìêèì, íè òèõèì ãîëîñîì, íî ÷ðåçâû÷àéíî óâåòëèâûì è ìàãíåòè÷åñêèì, - ÷òî ÿ íèêîãäà èç êîðûñòè íå ëå÷ó. Ýòî ïðîòèâíî ìîèì ïðàâèëàì è ìîåìó èñêóññòâó. Ïðàâäà, ÿ áåðó çà âèçèòû, íî åäèíñòâåííî ñ òåì òîëüêî, ÷òîáû íå îáèäåòü ìîèì îòêàçîì. Êîíå÷íî, ÿ áû ïðèñòàâèë âàø íîñ; íî ÿ âàñ óâåðÿþ ÷åñòüþ, åñëè óæå âû íå âåðèòå ìîåìó ñëîâó, ÷òî ýòî áóäåò ãîðàçäî õóæå. Ïðåäîñòàâüòå ëó÷øå äåéñòâèþ ñàìîé íàòóðû. Ìîéòå ÷àùå õîëîäíîþ âîäîþ, è ÿ âàñ óâåðÿþ, ÷òî âû, íå èìåÿ íîñà, áóäåòå òàê æå çäîðîâû, êàê åñëè áû èìåëè åãî.

All credits, òàê ñêàçàòü, -- Íèêîëàþ Âàñèëüåâè÷ó.

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr. îäîáðèë(à):
birdname îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #93  
Ñòàðûé 14.03.2007, 13:59
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò M_Osipov
À ïðî ÏÊÀ-òî, ÷òî ñêàæåòå, äîðîãîé saab?
"Ýòî, íåñîìíåííî, ÏÊÀ. Ïðî îñòàëüíîå ÿ óæå ïèñàë.

Êîììåíòàðèè ê ñîîáùåíèþ:
Anton Verbine îäîáðèë(à): Izrjadno .
Îòâåòèòü ñ öèòèðîâàíèåì
  #94  
Ñòàðûé 14.03.2007, 14:17
Delsol Delsol âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
 
Ðåãèñòðàöèÿ: 06.03.2007
Ñîîáùåíèé: 143
Delsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDelsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò saab
çàëîæèòå â áþäæåò ïàðó áîëüøèõ àìåðèêàíñêèõ ðóáëåé íà èíòåðíåò-òðàôèê è ïèøèòå íàì.
 ëþáîé áèáëèîòåêå èíòåðíåò unlimited.
Îòâåòèòü ñ öèòèðîâàíèåì
  #95  
Ñòàðûé 14.03.2007, 14:17
Àâàòàð äëÿ dmblok
dmblok dmblok âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.11.2006
Ãîðîä: Msk
Ñîîáùåíèé: 1,827
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 67 ðàç(à) çà 62 ñîîáùåíèé
dmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò alex_md
Êîëëåãè, íà 10 ñòðàíèöàõ ïîëíûõ ñàðêàçìà (èëè ìíå ïîêàçàëîñü) íåò ÍÈ ÎÄÍÎÉ ññûëêè íà äàííûå. Î ÷åì ýòî ãîâîðèò? Ïðàâèëüíî! Âñå ýòî, ñ ïîçâîëåíèÿ ñêàçàòü, êàòåãîðèÿ "C", à çíà÷èò êàæäûé èìååò ïðàâî ñîãëàñèòüñÿ, èëè íåò è äàæå ïðèäðàòüñÿ ê "àðôîãðàôôèè" âûïèñêè.
Óâàæàåìûé alex_md. Îòñóòñòâèå ïðèâåäåííûõ ññûëîê íà ïðåèìóùåñòâà àãðåññèâíîé òàêòèêè âåäåíèÿ áîëüíîãî â êîíêðåòíîì ñëó÷àå(class I) íå çíà÷èò, ÷òî èõ íåò âîâñå. Ïðîñòî ïðåäïîëàãàåòñÿ, ÷òî ëþäè ó÷àñòâóþùèå â äèñêóññèè ãîâîðÿò íà îäíîì ÿçûêå è êàêèå-òî âåùè îñòàþòñÿ çà ñêîáêàìè. Ñóùåñòâóþò îôèöèàëüíûå ðåêîìåíäàöèè êîèì, ïî-âèäèìîìó, è íàäî ñëåäîâàòü, ïî ìåðå ñèë è âîçìîæíîñòåé, êîíå÷íî.
PS Ïî òåìå: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Ñîîáùåíèå îò alex_md
 ñâÿçè ñ ýòèì, à êàêæå ñ îòñóòñòâèåì â ëèòåðàòóðå êàêèõ-ëèáî óáåäèòåëüíûõ äàííûõ çà òî, ÷òî ðåâàñêóëÿðèçàöèÿ ïðîäëèò æèçíü òàêîìó ïàöèåíòó (äàæå øóíòèðîâàíèå), êîíñåðâàòèâíàÿ òåðàïèÿ âûãëÿäèò ïðèâëåêàòåëüíî.
Íå ìîãó ñîãëàñèòüñÿ ñ Âàìè íà 100%. Ïðîñòî ñòåïåíü óáåäèòåëüíîñòè äëÿ âñåõ ðàçíàÿ. Êîíå÷íî ÷àñòü ñðàâíèòåëüíûõ èññëåäîâàíèé áûëî íà÷àòà åùå äî ðîæäåíèÿ íåêîòîðûõ ó÷àñòíèêîâ äèññêóñèè (íàïðèìåð Coronary Artery Surgery Study) è äèçàéí èõ âûçûâàåò âîïðîñû... È âñå-òàêè, êàê ïðèíÿòî ãîâîðèòü, åñòü îïðåäåëåííûé òðåíä.
PS Ìíå ïîêàçàëèñü èíòåðåñíûìè íåñòàíäàðòûå ñëàéäû ïî òåìå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Ñîîáùåíèå îò Delsol
Âàñ íàâåðíÿêà ðàçíûå ëþäè áóäóò ïðîñèòü ïåðåäàòü äëÿ àìåðèêàíñêèõ ðîäñòâåííèêîâ è çíàêîìûõ âåùè ïåðâîé íåîáõîäèìîñòè. Ãëàâíîå íè çà ÷òî íå ñîãëàøàéòåñü âåçòè ñóøåíûå ãðèáû, âàðåíüå, ëèñòüÿ áåðåçû, ìåäâåæüè óøêè è ìóìèå. À òî íà òàìîæíå "âàñ æäóò îäíè íåïðèÿòíîñòè".
Óâàæàåìàÿ Delsol. Ìàêñèì Àëåêñàíäðîâè÷ îïûòíûé êîíòðàáàíäèñò è âîîáùå ãðàæäàíèí ìèðà
Îòâåòèòü ñ öèòèðîâàíèåì
  #96  
Ñòàðûé 14.03.2007, 14:21
dr.Ira dr.Ira âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 13.03.2005
Ãîðîä: Èçðàèëü
Ñîîáùåíèé: 9,362
Ïîáëàãîäàðèëè 1,803 ðàç(à) çà 1,491 ñîîáùåíèé
dr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr.Ira ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
////////////
Îòâåòèòü ñ öèòèðîâàíèåì
  #97  
Ñòàðûé 14.03.2007, 14:29
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Delsol
Âîçìîæíî è ñóùåñòâóþò ïóáëèêàöèè ïîääåðæèâàþùèå âàøó òî÷êó çðåíèÿ. Íî âñå æå áîëüøèíñòâî êàðäèîëîãîâ ñ÷èòàåò, ÷òî æèçíåñïîñîáíîñòü ìèîêàðäà äëÿ ðåøåíèÿ âîïðîñà î ðåâàñêóëÿðèçàöèè íóæíî îöåíèâàòü èíà÷å. Èçâèíèòå.
Óâàæàåìûé Delsol! Ìíå òðóäíî ïîíÿòü, ÷òî òàêîå "áîëüøèíñòâî êàðäèîëîãîâ" è òåì áîëåå îöåíèòü ýòî "áîëüøèíñòâî". Îöåíêà æèçíåñïîñîáíîãî ìèîêàðäà - ýòî ÷àñòü ìîåé ïðîôåññèîíàëüíîé äåÿòåëüíîñòè. Íà ýòî òåìó ÿ ìîãó ãîâîðèòü ëèøü êîíêðåòíî. Ñ óâàæåíèåì, Âàø ÎÅÍ.

Îñîáåííî ìíå ïîíðàâèëîñü Âàøå "Âîçìîæíî è ñóùåñòâóþò ïóáëèêàöèè ïîääåðæèâàþùèå âàøó òî÷êó çðåíèÿ." Èíòåðåñíî âñå-òàêè ñóùåñòâóþò èëè íåò? Âû èõ íå íàøëè? Íåóæåëè ÿ îáìàíóë Âàñ è ââåë â çàáëóæäåíèå îáùåñòâåííîñòü?
Îòâåòèòü ñ öèòèðîâàíèåì
  #98  
Ñòàðûé 14.03.2007, 15:13
Àâàòàð äëÿ dmblok
dmblok dmblok âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.11.2006
Ãîðîä: Msk
Ñîîáùåíèé: 1,827
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 67 ðàç(à) çà 62 ñîîáùåíèé
dmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ostroumov
...Îöåíêà æèçíåñïîñîáíîãî ìèîêàðäà - ýòî ÷àñòü ìîåé ïðîôåññèîíàëüíîé äåÿòåëüíîñòè. Íà ýòî òåìó ÿ ìîãó ãîâîðèòü ëèøü êîíêðåòíî....
Öèòàòà:
Ñîîáùåíèå îò ostroumov

Îñîáåííî ìíå ïîíðàâèëîñü Âàøå "Âîçìîæíî è ñóùåñòâóþò ïóáëèêàöèè ïîääåðæèâàþùèå âàøó òî÷êó çðåíèÿ." Èíòåðåñíî âñå-òàêè ñóùåñòâóþò èëè íåò? Âû èõ íå íàøëè? Íåóæåëè ÿ îáìàíóë Âàñ è ââåë â çàáëóæäåíèå îáùåñòâåííîñòü?
Óâàæàåìûé Åâãåíèé Íèêîëàåâè÷. Âàøà ïðîôåññèîíàëüíàÿ äåÿòåëüíîñòü âûçûâàåò âñÿ÷åñêîå óâàæåíèå è â çàáëóæäåíèå Âû íèêîãî íå ââîäèòå.

Öèòàòà:
Ñîîáùåíèå îò ostroumov
....Ìíå îáñóæäåíèå ïîêàçàëî, ÷òî êîëè÷åñòâåííàÿ îöåíêà æèçíåñïîñîáíîñòè ìèîêàðäà ðàíî èëè ïîçäíî âñòàíåò ïåðåä êàæäûì èç âàñ è çàñòàâèò, òàê èëè èíà÷å, ïðèîáùèòüñÿ ê «ìèðîâîìó îïûòó»....
Ìû âñåãäà ðàäû ïðèîáùèòüñÿ ê ìèðîâîìó îïûòó, â òîì ÷èñëå è ñ Âàøåé ëþáåçíîé ïîìîùüþ. Íàøå íåïîíèìàíèå, êàê ìíå êàæåòñÿ, âîçíèêëî èñêëþ÷èòåëüíî ïî íåäîðàçóìåíèþ. Ïðîñòî ñ ìîåé òî÷êè çðåíèÿ Âû èíîãäà ñòàâèòå çíàê ðàâåíñòâà ìåæäó ðåàëüíûì íàëè÷èåì/îòñóñòâèåì æèçíåñïîñîáíîãî ìèîêàðäà è âûÿâëåíèåì/íåâûÿâëåíèåì îíîãî ñ ïîìîùüþ Âàøèõ ïðîãðåññèâíûõ ìåòîäèê.  ñâÿçè ñ ýòèì âñïîìèíàåòñÿ ñòàðûé åâðåéñêèé àíåêäîò.


Ïðèåçæèé ñïðàøèâàåò îäåññèòà:
— Ñêàæèòå, åñëè ÿ ïîéäó ïî ýòîé óëèöå, òàì áóäåò âîêçàë?
— Ïîñëóøàéòå, óâàæàåìûé, òàì áóäåò âîêçàë, äàæå åñëè Âû íå ïîéäåòå ïî ýòîé óëèöå.

Ýòî ÿ ê òîìó, ÷òî êàê ìíå êàæåòñÿ, â íåêîòîðûõ ñëó÷àÿõ (ñì. çàêðûòóþ íà çàìîê òåìó) æèçíåñïîñîáíûé ìèîêàðä ïðèñóòñòâóåò, äàæå åñëè îí Âàìè è íå çàðåãèñòðèðîâàí.

Ñ óâàæåíèåì.

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr. îäîáðèë(à):
Gilarov îäîáðèë(à): Èíòåðåñíî, à êîãäà çàðåãèñòðèðîâàí, íî îòñóòñòâóåò, òàê áûâàåò?
birdname îäîáðèë(à):
VanushkoVE îäîáðèë(à):
DrSusha îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #99  
Ñòàðûé 14.03.2007, 15:21
Delsol Delsol âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
 
Ðåãèñòðàöèÿ: 06.03.2007
Ñîîáùåíèé: 143
Delsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDelsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò dmblok
Óâàæàåìàÿ Delsol. Ìàêñèì Àëåêñàíäðîâè÷ îïûòíûé êîíòðàáàíäèñò è âîîáùå ãðàæäàíèí ìèðà
Ýòî õîðîøî. Çíà÷èò ó Ìàêñèìà Àëåêñàíäðîâè÷ íå áóäåò ïðîáëåì ñ ìåòðî.


P.S.
Evaluation of myocardial viability after myocardial infarction
R. Krishnamani and R. Senior*
Northwick Park Hospital, Harrow, Middlesex, U.K.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

The Scintigraphic Evaluation of Myocardial Viability with Tc-99m Sestamibi and FDG
Jac D. Scheiner, MD
J. Anthony Parker, MD, PhD
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography
Hunold P, Brandt-Mainz K, Freudenberg L, Vogt FM, Neumann T, Knipp S, Barkhausen J.
Institut fur Diagnostische und Interventionelle Radiologie, Universitatsklinikum Essen.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Optimal viability evaluation by a simplified rest redistribution thallium-201 & contractility assessment with low dose dobutamine combined protocol.
Journal of Nuclear Cardiology, Volume 11, Issue 4, Pages S36-S37
S. Heiba, G. Yee, J. Coppola, T. Elmquist, R. Braff, I. Youssef, J. Ambrose, H. Abdel-Dayem
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Cardiac SPECT with iodine-123-labeled fatty acids : evaluation of myocardial viability with BMIPP
Auteur(s) / Author(s)
KNAPP F. F. ; FRANKEN P. ; KROPP J. ;
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Does intraoperative evaluation of left ventricular contractile reserve predict myocardial viability? A clinical study using dobutamine stress echocardiography in patients undergoing coronary artery bypass graft surgery
Auteur(s) / Author(s)
LEUNG Jacqueline M. (1) ; BELLOWS Wayne H. (2) ; PASTOR Darwin (1) ;
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Role of Thallium-201 and PET Imaging in Evaluation of Myocardial Viability and Management of Patients with Coronary Artery Disease and Left Ventricular Dysfunction
Jamshid Maddahi, Heinrich Schelbert, Richard Brunken and Marcelo Di Carli
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Invest Radiol. 2007 Apr;42(4):248-255.Improved Evaluation of Myocardial Perfusion and Viability With the Magnetic Resonance Blood Pool Contrast Agent P792 in a Nonreperfused Porcine Infarction Model.Peukert D, Kaufels N, Laule M, Schnorr J, Carme S, Farr T, Schonenberger E, Taupitz M, Hamm B, Dewey M.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Expert Rev Cardiovasc Ther. 2007 Mar;5(2):307-21. Links
Cardiovascular MRI: its current and future use in clinical practice.Rehwald WG, Wagner A, Sievers B, Kim RJ, Judd RM.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

J Thorac Imaging. 2007 Feb;22(1):35-9. Links
Coronary CTA: indications, patient selection, and clinical implications.Thilo C, Auler M, Zwerner P, Costello P, Schoepf UJ.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

J Nucl Med. 2006 Jan;47(1):74-82. Links
Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease.Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, Fieno DS, Germano G, Slomka P, Wong ND, Kang X, Rozanski A.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

J Nucl Med. 2006 Jul;47(7):1107-18. Links
Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease.Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, Fieno DS, Germano G, Wong ND, Kang X, Rozanski A.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #100  
Ñòàðûé 14.03.2007, 15:21
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò dmblok
[color=black]Óâàæàåìûé Åâãåíèé Íèêîëàåâè÷. ...

Ýòî ÿ ê òîìó, ÷òî êàê ìíå êàæåòñÿ, â íåêîòîðûõ ñëó÷àÿõ (ñì. çàêðûòóþ íà çàìîê òåìó) æèçíåñïîñîáíûé ìèîêàðä ïðèñóòñòâóåò, äàæå åñëè îí Âàìè è íå çàðåãèñòðèðîâàí.

Ñ óâàæåíèåì.
Óâàæàåìûé dmblok! ß ðàä, ÷òî Âû íà ìåíÿ íå îáèäåëèñü. Àíåêäîò ïîíðàâèëñÿ, ñïàñèáî. Ïî ïîâîäó "æèçíåñïîñîáíûé ìèîêàðä ïðèñóòñòâóåò, äàæå åñëè îí Âàìè è íå çàðåãèñòðèðîâàí", êîíå÷íî, ìîæåò áûòü âñÿêîå - âàæåí ðåçóëüòàò. Åñëè Âû èìååòå â âèäó áîëüíîãî èç êàðäèîöåíòðà, êîòîðîãî ÿ ñìîòðåë íåñêîëüêî íåäåëü íàçàä, ìîæíî ïîñìîòðåòü åãî ïîñëå îïåðàöèè è ñðàâíèòü ðåçóëüòàòû. Ñ óâàæåíèåì ê Âàì. ÎÅÍ.

Êîììåíòàðèè ê ñîîáùåíèþ:
Dr. îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #101  
Ñòàðûé 14.03.2007, 15:31
Àâàòàð äëÿ dmblok
dmblok dmblok âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.11.2006
Ãîðîä: Msk
Ñîîáùåíèé: 1,827
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 67 ðàç(à) çà 62 ñîîáùåíèé
dmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådmblok ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ostroumov
Åñëè Âû èìååòå â âèäó áîëüíîãî èç êàðäèîöåíòðà, êîòîðîãî ÿ ñìîòðåë íåñêîëüêî íåäåëü íàçàä, ìîæíî ïîñìîòðåòü åãî ïîñëå îïåðàöèè è ñðàâíèòü ðåçóëüòàòû. Ñ óâàæåíèåì ê Âàì. ÎÅÍ.
Îí ïëàíèðóòñÿ íà ÊØ â àïðåëå...
Îòâåòèòü ñ öèòèðîâàíèåì
  #102  
Ñòàðûé 14.03.2007, 15:37
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò dmblok
Îí ïëàíèðóòñÿ íà ÊØ â àïðåëå...
Óâàæàåìûé dmblok! Îòëè÷íî! Òîëüêî íå çàáóäüòå ïðî ðåçóëüòàòû ñòðåññ- ýõî, êîòîðûå îí ïðèíîñèë ñ ñîáîé ìíå íà èññëåäîâàíèå. Çàêëþ÷åíèå ÿ ïèñàë "â îòâåò" íà íèõ! Åñëè âîçíèêíåò íåîáõîäèìîñòü íàïèñàòü ìíå íàïðÿìóþ - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïî÷òó ïðîâåðÿþ êàæäûé äåíü. Ñ óâàæåíèåì ÎÅÍ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #103  
Ñòàðûé 14.03.2007, 16:22
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Delsol
P.S. Evaluation of myocardial viability after myocardial infarction
R. Krishnamani and R. Senior*
Northwick Park Hospital, Harrow, Middlesex, U.K.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]...
Óâàæàåìûé Delsol! Ìåòîäîâ ìíîãî ðàçíûõ... [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îíè îò 2003 ãîäà. Òàì, â òàáëè÷êå 17 åñòü òàê íå ïîíðàâèâøèéñÿ Âàì Gated-SPECT. Íî èìåéòå â âèäó, òàì îí òîëüêî â ïîêîå - áåç ïðîá ñ íèòðîãëèöåðèíîì. Áîëåå ïîçäíèå ðàáîòû, íå âîøåäøèå â ýòè ãàéäû è öèòèðóåìûå ìíîþ â "çàêðûòîé íà çàìîê" òåìå ïîêàçûâàþò, ÷òî ýòî íàèáîëåå áûñòðî ïðîãðåññèðóþùèé ìåòîä. Âàæíî, ÷òî îáèëèå èíôîðìàöèè ïîäàâàåìîå èì, ïîçâîëÿåò èñïîëüçîâàòü åãî íå òîëüêî äëÿ îöåíêè æèçíåñïîñîáíîñòè. Ñ óâàæåíèåì ê Âàì ÎÅÍ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #104  
Ñòàðûé 14.03.2007, 16:35
Delsol Delsol âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
 
Ðåãèñòðàöèÿ: 06.03.2007
Ñîîáùåíèé: 143
Delsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDelsol ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åñëè âàì íåòðóäíî, ðàññêàæèòå, ïîæàëóéñòà, êàêèì îáðàçîì áûëè îöåíåíû ñïåöèôè÷íîñòü è ÷óâñòâèòåëüíîñòü Gated MIBI SPECT ñ íèòðîãëèöåðèíîì ïî ñðàâíåíèþ ñ áîëåå ïðèâû÷íûìè ìåòîäàìè îöåíêè æèçíåñïîñîáíîñòè ìèîêàðäà? Ìîæíî ñ ïîìîùüþ ññûëîê. Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #105  
Ñòàðûé 14.03.2007, 17:20
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Delsol
Åñëè âàì íåòðóäíî, ðàññêàæèòå, ïîæàëóéñòà, êàêèì îáðàçîì áûëè îöåíåíû ñïåöèôè÷íîñòü è ÷óâñòâèòåëüíîñòü Gated MIBI SPECT ñ íèòðîãëèöåðèíîì ïî ñðàâíåíèþ ñ áîëåå ïðèâû÷íûìè ìåòîäàìè îöåíêè æèçíåñïîñîáíîñòè ìèîêàðäà? Ìîæíî ñ ïîìîùüþ ññûëîê. Ñïàñèáî.
Óâàæàåìûé Delsol! Âîò ïàðà àáñòðàêòîâ ïîëíîñòüþ
Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PETWei He, MD,a Wanda Acampa, MD,a,b Ciro Mainolfi, MD,a Francesco Menna, MD,a Anna Rita Sorrentino, MD,a,c Mario Petretta, MD,d and Alberto Cuocolo, MDa,c
Background. In patients with ischemic left ventricular (LV) dysfunction, myocardial perfusion imaging after nitrate administration may improve the identification of dysfunctional but viable myocardium. This study was designed to assess the relationship between tetrofosmin uptake after nitrate administration and metabolic activity as assessed by positron emission
tomography (PET) in patients with ischemic LV dysfunction.
Methods and Results. Thirty-six patients with chronic myocardial infarction and LV dysfunction (ejection fraction, 35%  6%) underwent resting technetium 99m tetrofosmin single photon emission computed tomography (SPECT) imaging under control conditions (baseline) and after sublingual administration of 10 mg isosorbide dinitrate. Within 1 week, all patients underwent metabolic PET imaging with fluorine 18–fluorodeoxyglucose. Tetrofosmin uptake and metabolic activity were measured in 13 segments/patient. Regional LV function was assessed in corresponding segments by echocardiography. On baseline tetrofosmin imaging, 53 (40%) of the 131 akinetic or dyskinetic segments had reduced (<55% of peak activity) tracer uptake. Of these segments, 14 (26%) showed enhanced tetrofosmin uptake after nitrate administration (>10% vs baseline) and the remaining 38 (74%) did not change. The sensitivity and specificity of baseline tetrofosmin SPECT for detecting preserved metabolic activity were
69% and 86%, respectively. After nitrate administration, the sensitivity was higher (81%, P <.05 vs baseline) whereas the specificity was not different (86%, P  not significant). Concordance between tetrofosmin SPECT and PET in differentiating viable and necrotic myocardium was observed in 94 (72%) of the 131 akinetic or dyskinetic segments at baseline (k= 0.35) and
in 108 segments (82%) after nitrate administration (k= 0.53).
Conclusions. After nitrate administration, tetrofosmin uptake in dysfunctional segments correlated with metabolic activity as assessed by fluorodeoxyglucose PET imaging better than baseline. Thus tetrofosmin SPECT after nitrate administration may improve the identification of ischemic but still viable myocardium in patients with chronic ischemic LV dysfunction. (J Nucl Cardiol 2003;10:599-606.)
Key Words: Tetrofosmin • cardiac metabolism • nitrate • left ventricular dysfunction

Baseline/Postnitrate Tetrofosmin SPECT for Myocardial Viability Assessment in Patients with Postischemic Severe Left Ventricular Dysfunction: New Evidence from MRIAssuero Giorgetti, MD; Alessandro Pingitore, MD, PhD; Brunella Favilli, MSc; Annette Kusch, RT; Massimo Lombardi, MD; and Paolo Marzullo, MD
The aim of this study was to compare 99mTc-tetrofosmin SPECT with contrast-enhanced MRI (ceMRI), a new direct sign of myocardial fibrosis. Methods: We studied 21 patients (age, 60  11 y;19 male) with previous myocardial infarction and severe left ventricular dysfunction (ceMRI EF, 29%6%). All patients underwent resting and postnitrate (intravenous isosorbide dinitrate) 99mTctetrofosmin gated SPECT as well as ceMRI. Scintigraphic analysis was performed using quantitative perfusion SPECT (QPS), providing the percentage radiotracer uptake and defect severity in a 20-segment model. Hyperenhancement was defined by the increase of ceMRI signal intensity 20 min after intravenous injection of gadolinium–diethylenetriaminepentaacetic acid and its regional extension as the percentage of the total segment area. Results: In ceMRI dysfunctional segments, the correlation between the extent of hyperenhancement and both 99mTc-tetrofosmin uptake and defect severity was significantly better after nitrate administration rather than at rest (P < 0.0001). Using a ceMRI cutoff below 40%, 102 of 196 (52%) segments were viable, whereas 94 (48%) segments were not viable. According to receiver-operating characteristic curve analysis, diagnostic accuracies were higher for postnitrate 99mTc-tetrofosmin uptake as well as perfusion defect severity
than using resting data (0.84 vs. 0.71, P<0.001; 0.89 vs. 0.76, P<0.001, respectively). Conclusion: After nitrate administration, 99mTc-tetrofosmin uptake and perfusion defect severity were closely related to ceMRI, demonstrating, in vivo, the existence of an inverse correlation between the transmural distribution of fibrosis and tracer delivery to the myocardium.
Key Words: myocardial viability; gated SPECT; contrast-enhanced
MRI; nitrates J Nucl Med 2005; 46:1285–1293

Ïî-ìîåìó àáñòðàêòû îáîèõ æóðíàëîâ äîëæíû áûòü â ñâîáîäíîì äîñòóïå. Áûòü ìîæåò Âû íàéäåòå è ÷òî-íèáóäü ïîíîâåé. Ñ óâàæåíèåì ÎÅÍ.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 03:47.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.